Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last month.
SetPoint Medical secures $140M to fund neuromodulation for arthritis
Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last month.